SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.31 Cr | ₹-1.26 Cr | - |
What is the latest Deferred Tax Assets / Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.31 Cr |
| Mar2024 | ₹-1.26 Cr |
| Mar2023 | - |
How is Deferred Tax Assets / Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.31 Cr | Negative | |
| Mar2024 | ₹-1.26 Cr | 0 | |
| Mar2023 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹8,774.5 Cr | 13.1% | 32.8% | 65.5% | Stock Analytics | |
| SAGILITY | ₹18,898.5 Cr | -2% | 3.5% | 0.7% | Stock Analytics | |
| PRIME FOCUS | ₹18,022.3 Cr | -4.6% | -6.4% | 56.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,514.1 Cr | -7% | -8.9% | -33.6% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,596.2 Cr | -6.6% | -7.5% | -4.9% | Stock Analytics | |
| INDEGENE | ₹11,906.5 Cr | -4% | -3.8% | -14.5% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 13.1% |
32.8% |
65.5% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses